中国抗体SM17再增一项适应症研究申请 针对治疗特应性皮炎（AD）的新药研究申请获国家药监局药品审评中心受理
Jun 12, 2023 20:45 HKT |  |
|
中國抗體SM17再增一項適應症研究申請 針對治療特應性皮炎（AD）的新藥研究申請獲國家藥監局藥品審評中心受理
Jun 12, 2023 20:44 HKT | |
|
SinoMab Submits another IND Application for SM17 for the Treatment of Atopic Dermatitis, Which was Accepted by NMPA CDE
Jun 12, 2023 20:43 HKT | |
|
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China
Jun 12, 2023 20:00 HKT |  |
|
国际助产士联合会在巴厘岛举行的第 33 届三年一度的大会上接待了数千名代表
Jun 09, 2023 13:00 HKT |  |
|
國際助產士聯合會在巴厘島舉行的第 33 屆三年一度的大會上接待了數千名代表
Jun 09, 2023 13:00 HKT | |
|
International Confederation of Midwives to Host Thousands of Delegates at Its 33rd Triennial Congress in Bali
Jun 08, 2023 23:00 HKT | |
|
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development, Presents major research results of birociclib, the start product, at the international stage in ASCO
Jun 08, 2023 21:18 HKT |  |
|
四环医药旗下轩竹生物创新研发全速前进 携明星产品吡罗西尼重磅研究成果登国际舞台于ASCO亮相
Jun 08, 2023 21:16 HKT | |
|
四環醫藥旗下軒竹生物創新研發全速前進 攜明星產品吡羅西尼重磅研究成果登國際舞台於ASCO亮相
Jun 08, 2023 21:15 HKT | |
|
Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer's Disease
Jun 08, 2023 06:26 HKT |  |
|
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry
Jun 06, 2023 20:00 HKT |  |
|
IMA ART Fertility 聯合創始人兼首席執行官 Michelle Tang 的創傷性流產, 迎來了一個女嬰的誕生
Jun 06, 2023 09:02 HKT |  |
|
IMA ART Fertility 联合创始人兼首席执行官 Michelle Tang 的创伤性流产, 迎来了一个女婴的诞生
Jun 06, 2023 09:01 HKT | |
|
Traumatic Miscarriage Precedes Birth of Baby Girl to Michelle Tang, Co-Founder & CEO of IMA ART Fertility
Jun 06, 2023 09:00 HKT | |
|
Asensus Shares First Quarter Results and Future Plans
Jun 01, 2023 21:40 HKT |  |
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China
May 30, 2023 23:00 HKT | |
|
2023 ASCO和BIO上的Avance Clinical：早期肿瘤治疗试验越来越复杂，对患者的需求也越来越大
May 30, 2023 11:00 HKT |  |
|
2023 ASCO和BIO上的Avance Clinical：早期腫瘤治療試驗越來越複雜，對患者的需求也越來越大
May 30, 2023 11:00 HKT | |
|
ASCO & BIO 2023에서 아방스 임상: 점점 더 정교해지고 더 많은 환자를 요구하는 초기 단계 종양학 시험
May 30, 2023 11:00 HKT | |
|